 |
 |
 |
|
HBsAg SEROCLEARANCE IN HIV AND HBV-COINFECTED
PATIENTS IN THE ERA OF TENOFOVIR-CONTAINING THERAPY
|
|
|
CROI 2025 SF March 9-12
u-Shan Huang1, Hsin-Yun Sun1, Li-Hsin Su1, Yi-Ching Su1, Wen-Chun Liu1, Wang-Huei Sheng1, Sui-Yuan Chang1, Chien-Ching Hung
1National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan






|
|
|
 |
 |
|
|